OvaScience Lands $37,000,000 Series B Financing

  • Feed Type
  • Date
    4/4/2012
  • Company Name
    OvaScience
  • Mailing Address
    800 Boylston Street Boston, MA 02199
  • Company Description
    The company is applying innovative science to improve the quality of eggs (oocytes) and increase the success of in vitro fertilization (IVF). OvaScience’s proprietary technology, exclusively licensed from Harvard Medical School and Massachusetts General Hospital, enables the use of a women’s own cellular energy to improve egg quality.
  • Website
    http://www.ovascience.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $37,000,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    OvaScience plans to use the proceeds from the financing to support the development and commercialization of its fertility treatment approaches based on the egg precursor cell discoveries of OvaScience co-founder Jonathan Tilly, Ph.D.
  • M&A Terms
  • Venture Investor
    General Catalyst Partners
  • Venture Investor
    Bessemer Venture Partners
  • Venture Investor
    Longwood Founders Fund
  • Venture Investor
    BBT Fund
  • Venture Investor
    Cycad Group
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.